UW Drug Discovery and Development Fee-for-Service Capabilities

The following laboratory facilities at UW-Madison provide state-of-the-art instrumentation and expert scientific staffs and have prior experience completing projects for Wisconsin and US companies.  Contact a single facility by clicking on the link to learn how they can help advance your drug discovery or development program.

UWCCC Small Molecule Screening and Synthesis Facility

  • HTS of small molecule libraries on cell-based or biochemical assays
  • Mechanism of action and profiling assays on client provided compounds
  • Medicinal and synthetic chemistry, scale-up synthesis, natural product purification
  • Analytical determination of chemical purity/identity via the Analytical Instrumentation Center
  • Molecular modeling and virtual screening

UWCCC Flow Cytometry

  • Single cell analysis
  • Single cell sorting: single cell deposition and bulk sorting of live cells
  • Comprehensive assay services: sample prep, data acquisition and analysis for immunophenotyping, cell cycle, DNA content, apoptosis, phagocytosis, calcium flux, cytokine and phosphoprotein detection, mitochondrial membrane potential, oxidative burst

UWCCC Experimental Pathology Shared Resource

  • Tissue processing, embedding and preparation of histologic sections
  • Standard and specialized histologic stains and enzyme-based histochemistry
  • Expert pathology consultation

UWCCC Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics Laboratory  

  • Pharmacokinetics (PK) and tissue distribution
  • Maximum tolerated dose (MTD) and optimal route of administration
  • Efficacy in xenograft and transgenic models
  • GLP compliant analysis (if needed)
  • HPLC, LC-MS, LC-MS/MS, genomic and immunoassay development and validation

UW School of Pharmacy: Zeeh Pharmaceutical Experiment Station

  • Drug, biologic and excipient physical/chemical characterization (pre-formulation)
  • Formulation
  • Analytical method development and validation
  • Stability testing
  • Structural elucidation: Analytical Instrumentation Center

Waisman Biomanufacturing

  • Chemistry, Manufacturing and Control (CMC) support for Investigational New Drug (IND) for biologics filings including Facility Master File (CBER/CDER)
  • Process development/qualification/validation
  • Assay qualification/validation
  • cGMP manufacturing of pre-clinical and clinical material
  • Quality control testing